Are there special considerations in the prescription of serotonin reuptake inhibitors for women?

Canadian Journal of Psychiatry

Volumn 43, Issue 9, 1998, Pages 900-904

  Stewart, Donna E ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Adverse drug reactions; Gender; Selective serotonin reuptake inhibitors

Indexed keywords

ALCOHOL; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; FLUOXETINE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SEX HORMONE;

ANXIETY NEUROSIS; CANADA; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL RESEARCH; DEPRESSION; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; PRENATAL EXPOSURE; PRESCRIPTION; PSYCHOPHARMACOTHERAPY; REVIEW; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SKIN DISEASE; TREATMENT PLANNING;

EID: 0032419074     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674379804300903     Document Type: Review

References (21)

1. Preskorn SH. Clinical pharmacology of selective serotonin reuptake inhibitors. Caddo (OK): Professional Communications, Inc. Publishing Corp; 1996.
2. Weisman M, Bland R, Joyce PR, Newman S, Wells JE, Wittchen H-U. Sex differences in rates of depression: cross-national perspectives. J Affect Disord 1993;29:77-84.
3. Astbury J. Crazy for you: the making of women's madness. Melbourne: Oxford University Press; 1996. p 13-36.
4. Stewart DE. Can gender affect your health? In: Kolk AM, Bekker MHJ, Vliet KP, editors. Advances in women and health research. Amsterdam: Routledge. Forthcoming.
5. Steiner M, Lepage P, Dunn EJ. Serotonin and gender-specific psychiatric disorders. International Journal of Psychiatry in Clinical Practice 1997;1:3-13.
6. Jensvold MF. Sex differences in psychotropic pharmacokinetics II. In: Jensvold MF, Halbreich N, Hamilton J, editors. Psychopharmacology and women: sex, gender and hormones. Washington (DC): American Psychiatric Press; 1996. p 43-71.
7. Stewart DE, Robinson GE. Psychotropic drugs and ECT in pregnancy and lactation. In: Stewart DE, Stotland NL, editors. Psychological aspects of women's health care. Washington (DC): American Psychiatric Press; 1993. p 71-96.
8. Stewart DE, Steiner M. Follicular and later luteal phase serum fluoxetine levels in women suffering from late lutea! phase dysphoric disorder. Biol Psychiat 1994;36:201-2.
9. Steiner M, Steinberg S, Stewart DE, and others. Fluoxetine in premenstrual dysphoric disorder. N Engl J Med 1995;332:1530-4.
10. Yonkers K, Gullion C, Williams A, Novak K, Rush AJ. Paroxetine as a treatment for premenstrual dysphoric disorder. J Clin Psychopharmacol 1996;6:3-8.
11. Halbreich U, Smoller JW. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J Clin Psychiatry 1997;58:399-402.
12. Steiner M, Lamont J, Steinberg S, Stewart DE, Reid R, Streiner D. Effect of fluoxetine on menstrual cycle length in women with premenstrual dysphoria. Obstet Gynecol 1997;90:590-5.
13. The Fluoxetine Bulimia Nervosa Collaborative Study Group. Levine NR. Fluoxetine in the treatment of bulimia nervosa. Arch Gen Psychiatry 1992;49:139-47.
14. Nulman I, Rovet J, Stewart DE, Wolpin J, Gardner HA, Theis JGW, and others. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997;4:258-62.
15. Kulin N, Pastuszak A, Sage SR, Schick-Boschetto B, Spivey G, Feldkamp M, and others. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors. JAMA 1998;278:609-10.
16. Pastuszak A, Schick-Boschetto B, Zuber C, Feldkamp O. Pregnancy outcomes following first trimester exposure to fluoxetine. JAMA 1993;269:2246-8.
17. Wisner KL, Perel JM. Serum nortriptyline levels in nursing mothers and their infants. Am J Psychiatry 1991;149:1234-6.
18. Charney D, Stewart DE. Psychiatric disorders in menopause. In: Stewart DE, Robinson GE, editors. A clinician's guide to menopause. Washington (DC): American Psychiatric Press; 1997. p 129-44.
19. Klaiser E, Broverman DM, Vogel W, and others. Therapy for severe persistent depressions in women. Arch Gen Psychiatry 1979;36:550-4.
20. Stahl SM. Basic psychopharmacology of antidepressants. Part 2: estrogen as an adjunct to antidepressant treatment. J Clin Psychiatry 1998;59 Suppl 4;15-24.
21. Aldrich AP, Cook MD, Pedersen LR. Retrospective review of selective serotonin reuptake inhibitor-induced libido disturbance in women. Clinical Drug Investigation 1996;11:353-9.